We are analyzing https://link.springer.com/article/10.1007/s11427-019-1629-6.

Title:
Cellular senescence: from anti-cancer weapon to anti-aging target | Science China Life Sciences
Description:
Cellular senescence (CS) is a state of stable cell cycle arrest characterized by the production and secretion of inflammatory molecules. Early studies described oncogene-induced senescence (OIS) as a barrier to tumorigenesis, such that the therapeutic induction of CS might represent a rational anti-cancer strategy. Indeed, the validity of this approach has been borne out by the development and approval of the cyclin-dependent kinase (CDK) inhibitor palbociclib for the treatment of breast cancer. Apart from tumors, senescent cells have also been shown to accumulate during natural mammalian aging, where they produce detrimental effects on the physiology of surrounding tissues. Thus, pharmacological senescent cell depletion has been proposed as an approach to delay age-related functional decline; this has been formally demonstrated in animal models. In this review article, we describe the current mechanistic understanding of cellular senescence at the molecular level and how it informs the development of new therapeutic strategies to combat cancer and aging.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Telecommunications

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

pubmed, article, google, scholar, cas, senescence, central, cell, cellular, cancer, cells, nature, aging, wang, nat, senescent, biol, sci, dna, usa, science, yuan, chen, campisi, uhrf, vivo, commun, alexander, oncogeneinduced, development, human, van, response, serrano, privacy, cookies, content, cdk, mammalian, factor, tumor, proc, natl, acad, sharpless, rev, ding, senescenceassociated, damage, disease,

Topics {✒️}

national disability-adjusted life-years month download article/chapter alexander & xiao-fan wang interleukin-dependent inflammatory network china life sci promotes keratinocyte dis-cohesion rb-mediated heterochromatin formation rational anti-cancer strategy healthy life expectancy oncogene-induced senescence relayed telomeres shorten xiao-fan wang full article pdf cancer therapy anti-aging target review privacy choices/manage cookies idiopathic pulmonary fibrosis harvard medical school sra protein uhrf1 male germ cells mammalian cellular senescence maintaining dna methylation murine liver carcinomas p16ink4a-luciferase model assess cellular senescence suppressing cellular senescence oncogene-induced senescence suppress senescence induced plasminogen activator inhibitor-1 senolytic drugs cellular transformation process cyclin-dependent kinase programmed cell senescence anti-cancer weapon article yuan histone h3 tail l1 drives ifn liver tumor surveillance autophagy maintains stemness hemi-methylated dna critical downstream target healthy aging dna damage response anti-aging target european economic area produce detrimental effects current mechanistic understanding double edged sword ink4a-arf locus cytosolic chromatin fragments

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Cellular senescence: from anti-cancer weapon to anti-aging target
         description:Cellular senescence (CS) is a state of stable cell cycle arrest characterized by the production and secretion of inflammatory molecules. Early studies described oncogene-induced senescence (OIS) as a barrier to tumorigenesis, such that the therapeutic induction of CS might represent a rational anti-cancer strategy. Indeed, the validity of this approach has been borne out by the development and approval of the cyclin-dependent kinase (CDK) inhibitor palbociclib for the treatment of breast cancer. Apart from tumors, senescent cells have also been shown to accumulate during natural mammalian aging, where they produce detrimental effects on the physiology of surrounding tissues. Thus, pharmacological senescent cell depletion has been proposed as an approach to delay age-related functional decline; this has been formally demonstrated in animal models. In this review article, we describe the current mechanistic understanding of cellular senescence at the molecular level and how it informs the development of new therapeutic strategies to combat cancer and aging.
         datePublished:2020-02-13T00:00:00Z
         dateModified:2020-02-13T00:00:00Z
         pageStart:332
         pageEnd:342
         sameAs:https://doi.org/10.1007/s11427-019-1629-6
         keywords:
            cellular senescence
            cancer
            healthy aging
            pro-senescence cancer therapy
            senolytic therapies
            Life Sciences
            general
         image:
         isPartOf:
            name:Science China Life Sciences
            issn:
               1869-1889
               1674-7305
            volumeNumber:63
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Science China Press
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Lifeng Yuan
               affiliation:
                     name:Boston Children’s Hospital
                     address:
                        name:Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, USA
                        type:PostalAddress
                     type:Organization
                     name:Harvard Medical School
                     address:
                        name:Department of Genetics, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter B. Alexander
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Duke University Medical Center, Durham, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiao-Fan Wang
               affiliation:
                     name:Duke University Medical Center
                     address:
                        name:Duke University Medical Center, Durham, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Cellular senescence: from anti-cancer weapon to anti-aging target
      description:Cellular senescence (CS) is a state of stable cell cycle arrest characterized by the production and secretion of inflammatory molecules. Early studies described oncogene-induced senescence (OIS) as a barrier to tumorigenesis, such that the therapeutic induction of CS might represent a rational anti-cancer strategy. Indeed, the validity of this approach has been borne out by the development and approval of the cyclin-dependent kinase (CDK) inhibitor palbociclib for the treatment of breast cancer. Apart from tumors, senescent cells have also been shown to accumulate during natural mammalian aging, where they produce detrimental effects on the physiology of surrounding tissues. Thus, pharmacological senescent cell depletion has been proposed as an approach to delay age-related functional decline; this has been formally demonstrated in animal models. In this review article, we describe the current mechanistic understanding of cellular senescence at the molecular level and how it informs the development of new therapeutic strategies to combat cancer and aging.
      datePublished:2020-02-13T00:00:00Z
      dateModified:2020-02-13T00:00:00Z
      pageStart:332
      pageEnd:342
      sameAs:https://doi.org/10.1007/s11427-019-1629-6
      keywords:
         cellular senescence
         cancer
         healthy aging
         pro-senescence cancer therapy
         senolytic therapies
         Life Sciences
         general
      image:
      isPartOf:
         name:Science China Life Sciences
         issn:
            1869-1889
            1674-7305
         volumeNumber:63
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Science China Press
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Lifeng Yuan
            affiliation:
                  name:Boston Children’s Hospital
                  address:
                     name:Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, USA
                     type:PostalAddress
                  type:Organization
                  name:Harvard Medical School
                  address:
                     name:Department of Genetics, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter B. Alexander
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Duke University Medical Center, Durham, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiao-Fan Wang
            affiliation:
                  name:Duke University Medical Center
                  address:
                     name:Duke University Medical Center, Durham, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Science China Life Sciences
      issn:
         1869-1889
         1674-7305
      volumeNumber:63
Organization:
      name:Science China Press
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Boston Children’s Hospital
      address:
         name:Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, USA
         type:PostalAddress
      name:Harvard Medical School
      address:
         name:Department of Genetics, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Duke University Medical Center, Durham, USA
         type:PostalAddress
      name:Duke University Medical Center
      address:
         name:Duke University Medical Center, Durham, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Lifeng Yuan
      affiliation:
            name:Boston Children’s Hospital
            address:
               name:Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, USA
               type:PostalAddress
            type:Organization
            name:Harvard Medical School
            address:
               name:Department of Genetics, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:Peter B. Alexander
      affiliation:
            name:Duke University Medical Center
            address:
               name:Duke University Medical Center, Durham, USA
               type:PostalAddress
            type:Organization
      name:Xiao-Fan Wang
      affiliation:
            name:Duke University Medical Center
            address:
               name:Duke University Medical Center, Durham, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, USA
      name:Department of Genetics, Harvard Medical School, Boston, USA
      name:Duke University Medical Center, Durham, USA
      name:Duke University Medical Center, Durham, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(324)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.59s.

LINK . SPRINGER . COM {}